FIELD: biotechnology.
SUBSTANCE: invention relates to a composition of medium for rejuvenation of mesenchymal stem cells of an elderly subject, containing FBS (foetal bovine serum), 0.5-1 ng/ml selenium, 10-50 ng/ml EGF (epidermal growth factor), 1-100 ng/ml bFGF (basic fibroblast growth factor) and NAC (N-acetyl-L-cysteine). Also a method for rejuvenation of mesenchymal stem cells of an elderly subject is disclosed, comprising culturing mesenchymal stem cells in an elderly subject in the above medium composition.
EFFECT: invention enables to increase significantly the efficiency of cell therapy with the use of mesenchymal stem cells.
5 cl, 12 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ISOLATION OF PLURIPOTENT STEM CELLS FROM UMBILICAL BLOOD EXPRESSING ZNF281 | 2010 |
|
RU2511417C2 |
| METHOD FOR INDUCING STEM CELL MIGRATION IN FATTY TISSUE | 2010 |
|
RU2527182C2 |
| CULTURE ENVIRONMENT FOR MESENCHYMAL STEM CELLS OF HUMAN | 2013 |
|
RU2640556C2 |
| METHOD OF OBTAINING EXOSOMES ORIGINING FROM MESENCHYMAL STEM CELLS AND A CULTURAL SOLUTION PRODUCED FROM THEM | 2020 |
|
RU2799432C1 |
| METHOD FOR PREPARATION AND INDUCTION OF DIRECTIONAL DIFFERENTIATION OF MULTIPOTENT CARDIAC CELL CULTURE FOR CELL-BASED THERAPY AND/OR TISSUE ENGINEERING WITHIN MYOCARDIAL ISCHEMIA | 2008 |
|
RU2366706C1 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2008 |
|
RU2465323C2 |
| METHOD OF CONSTRUCTING MASS OF MYOCARDIAL CELLS AND USE OF MASS OF MYOCARDIAL CELLS | 2008 |
|
RU2467066C2 |
| METHOD FOR EXPERIMENTAL ESTABLISHMENT OF THROMBOSED VEIN FLOW | 2012 |
|
RU2490722C1 |
| METHOD FOR SCREENING REGENERATION-PROMOTING NEURONAL CELLS HAVING NEURONAL REGENERATIVE ACTIVITY | 2022 |
|
RU2819367C1 |
| DIFFERENTIATION OF HUMAN EMBRYO STEM CELLS | 2008 |
|
RU2473685C2 |
